• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过体外基因转导过表达 LOTUS 进一步促进了人 iPSC-NS/PC 移植治疗外伤性脊髓损伤后运动功能的恢复。

LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury.

机构信息

Department of Orthopaedic Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan; Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan; Department of Orthopaedic Surgery, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo 152-8902, Japan.

Department of Orthopaedic Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

出版信息

Stem Cell Reports. 2021 Nov 9;16(11):2703-2717. doi: 10.1016/j.stemcr.2021.09.006. Epub 2021 Oct 14.

DOI:10.1016/j.stemcr.2021.09.006
PMID:34653401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8580872/
Abstract

Functional recovery is still limited mainly due to several mechanisms, such as the activation of Nogo receptor-1 (NgR1) signaling, when human induced pluripotent stem cell-derived neural stem/progenitor cells (hiPSC-NS/PC) are transplanted for subacute spinal cord injury (SCI). We previously reported the neuroprotective and regenerative benefits of overexpression of lateral olfactory tract usher substance (LOTUS), an endogenous NgR1 antagonist, in the injured spinal cord using transgenic mice. Here, we evaluate the effects of lentiviral transduction of LOTUS gene into hiPSC-NS/PCs before transplantation in a mouse model of subacute SCI. The transduced LOTUS contributes to neurite extension, suppression of apoptosis, and secretion of neurotrophic factors in vitro. In vivo, the hiPSC-NS/PCs enhance the survival of grafted cells and enhance axonal extension of the transplanted cells, resulting in significant restoration of motor function following SCI. Therefore, the gene transduction of LOTUS in hiPSC-NS/PCs could be a promising adjunct for transplantation therapy for SCI.

摘要

功能恢复仍然受到多种机制的限制,例如 Nogo 受体-1(NgR1)信号的激活,当人诱导多能干细胞衍生的神经干细胞/祖细胞(hiPSC-NS/PC)被移植用于亚急性脊髓损伤(SCI)时。我们之前曾报道过使用转基因小鼠过表达外侧嗅束引导物质(LOTUS),一种内源性 NgR1 拮抗剂,对损伤脊髓的神经保护和再生作用。在这里,我们评估了在亚急性 SCI 小鼠模型中,将 LOTUS 基因转导到 hiPSC-NS/PC 之前对其进行慢病毒转导的效果。转导的 LOTUS 有助于体外轴突延伸、抑制细胞凋亡和神经营养因子的分泌。在体内,hiPSC-NS/PC 增强了移植细胞的存活,并增强了移植细胞的轴突延伸,从而导致 SCI 后运动功能的显著恢复。因此,将 LOTUS 基因转导到 hiPSC-NS/PC 中可能是 SCI 移植治疗的一种有前途的辅助手段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddd/8580872/1891a70310a7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddd/8580872/81da23b691c0/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddd/8580872/e64a53e97519/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddd/8580872/b82f65b5f06e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddd/8580872/39c3baee066e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddd/8580872/4ca0e5654ee1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddd/8580872/559ff6cb5549/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddd/8580872/1891a70310a7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddd/8580872/81da23b691c0/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddd/8580872/e64a53e97519/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddd/8580872/b82f65b5f06e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddd/8580872/39c3baee066e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddd/8580872/4ca0e5654ee1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddd/8580872/559ff6cb5549/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddd/8580872/1891a70310a7/gr6.jpg

相似文献

1
LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury.通过体外基因转导过表达 LOTUS 进一步促进了人 iPSC-NS/PC 移植治疗外伤性脊髓损伤后运动功能的恢复。
Stem Cell Reports. 2021 Nov 9;16(11):2703-2717. doi: 10.1016/j.stemcr.2021.09.006. Epub 2021 Oct 14.
2
Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity.预评估的安全人诱导多能干细胞促进食蟹猴脊髓损伤后的功能恢复,无致瘤性。
PLoS One. 2012;7(12):e52787. doi: 10.1371/journal.pone.0052787. Epub 2012 Dec 27.
3
Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury.脊髓损伤后源自人诱导多能干细胞的神经干细胞/祖细胞移植的肿瘤发生细胞的选择性清除。
Stem Cells Transl Med. 2019 Mar;8(3):260-270. doi: 10.1002/sctm.18-0096. Epub 2018 Nov 28.
4
Long-term selective stimulation of transplanted neural stem/progenitor cells for spinal cord injury improves locomotor function.长期选择性刺激移植的神经干细胞/祖细胞可改善脊髓损伤后的运动功能。
Cell Rep. 2021 Nov 23;37(8):110019. doi: 10.1016/j.celrep.2021.110019.
5
Rehabilitative Training Enhances Therapeutic Effect of Human-iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury.康复训练增强人诱导多能干细胞源性神经干细胞/祖细胞移植治疗慢性脊髓损伤的疗效
Stem Cells Transl Med. 2023 Mar 3;12(2):83-96. doi: 10.1093/stcltm/szac089.
6
LOTUS Inhibits Neuronal Apoptosis and Promotes Tract Regeneration in Contusive Spinal Cord Injury Model Mice.莲心碱抑制挫伤性脊髓损伤模型小鼠神经元凋亡并促进脊髓损伤部位的轴突再生。
eNeuro. 2018 Dec 14;5(5). doi: 10.1523/ENEURO.0303-18.2018. eCollection 2018 Sep-Oct.
7
Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord.移植到损伤脊髓中的神经干细胞/祖细胞的髓鞘再生意义。
Stem Cells. 2011 Dec;29(12):1983-94. doi: 10.1002/stem.767.
8
Treatment with a Gamma-Secretase Inhibitor Promotes Functional Recovery in Human iPSC- Derived Transplants for Chronic Spinal Cord Injury.用γ-分泌酶抑制剂治疗促进慢性脊髓损伤的人诱导多能干细胞衍生移植物的功能恢复。
Stem Cell Reports. 2018 Dec 11;11(6):1416-1432. doi: 10.1016/j.stemcr.2018.10.022. Epub 2018 Nov 29.
9
Administration of C5a Receptor Antagonist Improves the Efficacy of Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in the Acute Phase of Spinal Cord Injury.C5a受体拮抗剂的给药可提高人诱导多能干细胞衍生的神经干细胞/祖细胞移植在脊髓损伤急性期的疗效。
J Neurotrauma. 2022 May;39(9-10):667-682. doi: 10.1089/neu.2021.0225.
10
Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury.用γ-分泌酶抑制剂预处理可预防人诱导多能干细胞衍生的脊髓损伤移植组织中的肿瘤样过度生长。
Stem Cell Reports. 2016 Oct 11;7(4):649-663. doi: 10.1016/j.stemcr.2016.08.015. Epub 2016 Sep 22.

引用本文的文献

1
Wnt signaling pathway in spinal cord injury: from mechanisms to potential applications.脊髓损伤中的Wnt信号通路:从机制到潜在应用
Front Mol Neurosci. 2024 Jul 24;17:1427054. doi: 10.3389/fnmol.2024.1427054. eCollection 2024.
2
Lateral olfactory tract usher substance (LOTUS), an endogenous Nogo receptor antagonist, ameliorates disease progression in amyotrophic lateral sclerosis model mice.外侧嗅束引导物质(LOTUS),一种内源性Nogo受体拮抗剂,可改善肌萎缩侧索硬化模型小鼠的疾病进展。
Cell Death Discov. 2023 Dec 14;9(1):454. doi: 10.1038/s41420-023-01758-7.
3
Hepatocyte growth factor pretreatment boosts functional recovery after spinal cord injury through human iPSC-derived neural stem/progenitor cell transplantation.

本文引用的文献

1
Nogo receptor antagonist LOTUS exerts suppression on axonal growth-inhibiting receptor PIR-B.Nogo 受体拮抗剂 LOTUS 对轴突生长抑制受体 PIR-B 发挥抑制作用。
J Neurochem. 2020 Nov;155(3):285-299. doi: 10.1111/jnc.15013. Epub 2020 Apr 13.
2
Moving beyond P values: data analysis with estimation graphics.超越P值:使用估计图进行数据分析。
Nat Methods. 2019 Jul;16(7):565-566. doi: 10.1038/s41592-019-0470-3.
3
LOTUS Inhibits Neuronal Apoptosis and Promotes Tract Regeneration in Contusive Spinal Cord Injury Model Mice.莲心碱抑制挫伤性脊髓损伤模型小鼠神经元凋亡并促进脊髓损伤部位的轴突再生。
肝细胞生长因子预处理通过人诱导多能干细胞衍生的神经干/祖细胞移植促进脊髓损伤后的功能恢复。
Inflamm Regen. 2023 Oct 16;43(1):50. doi: 10.1186/s41232-023-00298-y.
4
The Promising Role of a Zebrafish Model Employed in Neural Regeneration Following a Spinal Cord Injury.斑马鱼模型在脊髓损伤后神经再生中的应用前景。
Int J Mol Sci. 2023 Sep 11;24(18):13938. doi: 10.3390/ijms241813938.
5
Recent progress and challenges in the treatment of spinal cord injury.脊髓损伤治疗的最新进展和挑战。
Protein Cell. 2023 Sep 14;14(9):635-652. doi: 10.1093/procel/pwad003.
6
LOTUS suppresses amyloid β-induced dendritic spine elimination through the blockade of amyloid β binding to PirB.LOTUS 通过阻断淀粉样蛋白 β 与 PirB 的结合来抑制淀粉样蛋白 β 诱导的树突棘消除。
Mol Med. 2022 Dec 12;28(1):154. doi: 10.1186/s10020-022-00581-7.
7
Clinical Trials of Stem Cell Therapy in Japan: The Decade of Progress under the National Program.日本干细胞疗法的临床试验:国家项目下的十年进展
J Clin Med. 2022 Nov 28;11(23):7030. doi: 10.3390/jcm11237030.
8
Cell transplantation to repair the injured spinal cord.细胞移植修复脊髓损伤。
Int Rev Neurobiol. 2022;166:79-158. doi: 10.1016/bs.irn.2022.09.008. Epub 2022 Nov 9.
9
Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Promotes Forelimb Functional Recovery after Cervical Spinal Cord Injury.人诱导多能干细胞衍生的神经祖细胞移植促进颈脊髓损伤后的前肢功能恢复。
Cells. 2022 Sep 5;11(17):2765. doi: 10.3390/cells11172765.
10
Electro-acupuncture and its combination with adult stem cell transplantation for spinal cord injury treatment: A summary of current laboratory findings and a review of literature.电针及其与成体干细胞移植联合治疗脊髓损伤:当前实验室研究结果总结及文献复习。
CNS Neurosci Ther. 2022 May;28(5):635-647. doi: 10.1111/cns.13813. Epub 2022 Feb 17.
eNeuro. 2018 Dec 14;5(5). doi: 10.1523/ENEURO.0303-18.2018. eCollection 2018 Sep-Oct.
4
Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury.脊髓损伤后源自人诱导多能干细胞的神经干细胞/祖细胞移植的肿瘤发生细胞的选择性清除。
Stem Cells Transl Med. 2019 Mar;8(3):260-270. doi: 10.1002/sctm.18-0096. Epub 2018 Nov 28.
5
pirA- and pirB-like gene identification in Micrococcus luteus strains in Mexico.墨西哥藤黄微球菌菌株中pirA和pirB样基因的鉴定
J Fish Dis. 2018 Nov;41(11):1667-1673. doi: 10.1111/jfd.12874. Epub 2018 Jul 27.
6
Inducible Expression of GDNF in Transplanted iPSC-Derived Neural Progenitor Cells.诱导性表达 GDNF 于移植的 iPSC 源性神经前体细胞中。
Stem Cell Reports. 2018 Jun 5;10(6):1696-1704. doi: 10.1016/j.stemcr.2018.03.024. Epub 2018 Apr 26.
7
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.输血依赖型β-地中海贫血症患者的基因治疗。
N Engl J Med. 2018 Apr 19;378(16):1479-1493. doi: 10.1056/NEJMoa1705342.
8
Prior Treatment with Anti-High Mobility Group Box-1 Antibody Boosts Human Neural Stem Cell Transplantation-Mediated Functional Recovery After Spinal Cord Injury.预先用抗高迁移率族蛋白 B1 抗体处理可增强人神经干细胞移植对脊髓损伤后的功能恢复作用。
Stem Cells. 2018 May;36(5):737-750. doi: 10.1002/stem.2802. Epub 2018 Mar 8.
9
The Soluble Form of LOTUS inhibits Nogo Receptor-Mediated Signaling by Interfering with the Interaction Between Nogo Receptor Type 1 and p75 Neurotrophin Receptor.可溶性洛特鲁斯蛋白通过干扰 Nogo 受体 1 型与 p75 神经营养因子受体之间的相互作用抑制 Nogo 受体介导的信号转导。
J Neurosci. 2018 Mar 7;38(10):2589-2604. doi: 10.1523/JNEUROSCI.0953-17.2018. Epub 2018 Feb 9.
10
Regulation of axonal regeneration by the level of function of the endogenous Nogo receptor antagonist LOTUS.内源性 Nogo 受体拮抗剂 LOTUS 功能水平对轴突再生的调节。
Sci Rep. 2017 Sep 21;7(1):12119. doi: 10.1038/s41598-017-12449-6.